Myelodysplastic syndrome

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:disease
hematologic disorder
gptkbp:abbreviation gptkb:MDS
gptkbp:affects blood
bone marrow
gptkbp:can_be_secondary_to radiation therapy
chemotherapy
congenital syndromes
benzene exposure
gptkbp:can_progress_to gptkb:acute_myeloid_leukemia
gptkbp:cause cytopenia
ineffective hematopoiesis
gptkbp:diagnosedBy blood test
bone marrow biopsy
gptkbp:eponymOf preleukemia
gptkbp:firstDescribed 1976
gptkbp:has_cell_type dysplastic erythrocytes
dysplastic granulocytes
dysplastic megakaryocytes
gptkbp:has_genetic_abnormality gptkb:TP53_mutation
chromosome 5q deletion
chromosome 7q deletion
trisomy 8
https://www.w3.org/2000/01/rdf-schema#label Myelodysplastic syndrome
gptkbp:ICD-10_code D46
gptkbp:marking blasts in bone marrow
dysplasia in at least one cell line
ring sideroblasts
gptkbp:prognosis variable
gptkbp:prognostic_scoring_system IPSS
IPSS-R
gptkbp:riskFactor radiation exposure
genetic predisposition
older age
previous chemotherapy
gptkbp:subspecies 5q- syndrome
refractory anemia
refractory anemia with excess blasts
refractory cytopenia with multilineage dysplasia
gptkbp:symptom gptkb:anemia
fatigue
infections
easy bruising
gptkbp:treatment supportive care
chemotherapy
blood transfusion
growth factors
stem cell transplantation
gptkbp:bfsParent gptkb:MDS
gptkbp:bfsLayer 6